Research Article

Risk Factors of Lymph Node Metastasis in Patients with Pancreatic Neuroendocrine Tumors (PNETs)

Table 1

Detailed demographic, clinical, and pathological features of the study cohort.

No. of patients
()
Patients with LN metastases
()

Age at diagnosis years years
Sex
 Male1043 (53.3%)401 (53.6%)
 Female913 (46.7%)347 (46.4%)
Race
 White1289 (65.9%)510 (68.2%)
 Black223 (11.4%)94 (12.6%)
 Hispanic249 (12.7%)85 (11.4%)
 Asian168 (8.6%)51 (6.8%)
 Other27 (1.4%)8 (1.1%)
Marital status
 Unmarried607 (31.0%)233 (31.1%)
 Married1251 (64.0%)482 (64.4%)
 Unknown98 (5.0%)33 (4.4%)
Insurance status
 Uninsured47 (2.4%)17 (2.3%)
 Insured1689 (86.3%)619 (82.8%)
 Unknown220 (11.2%)112 (15.0%)
Tumor location
 Head632 (32.3%)295 (39.4%)
 Body and tail1016 (51.9%)332 (44.4%)
 Overlapping111 (5.7%)46 (6.1%)
 Other197 (10.1%)75 (10.0%)
Tumor size
 <2 cm526 (26.9%)75 (10.0%)
 2 cm-4 cm708 (36.2%)283 (37.8%)
 >4 cm718 (36.7%)389 (52.0%)
 Unknown4 (0.2%)1 (0.1%)
M stage
 M01644 (84.0%)521 (69.7%)
 M1301 (15.4%)221 (29.5%)
 Mx11 (0.6%)6 (0.8%)
Histology gradea
 Well differentiated1234 (63.1%)401 (53.6%)
 Moderately differentiated319 (16.3%)127 (17.0%)
 Poorly differentiated109 (5.6%)84 (11.2%)
 Undifferentiated24 (1.2%)18 (2.4%)
 Unknown270 (13.8%)118 (15.8%)

aHistology grade was based on WHO classification of tumors 4th edition.